MedPath

Effect of a Single Dose of Cranberry Beverage on Inflammation and Oxidative Stress

Not Applicable
Completed
Conditions
Inflammation
Interventions
Other: Low Calorie Cranberry Juice Cocktail
Other: Cranberry Extract Beverage
Other: Non-Cranberry Beverage
Registration Number
NCT01780922
Lead Sponsor
Washington State University
Brief Summary

The purpose of this study is to determine the effects of a single dose of cranberry beverage in healthy adults on the kinetic uptake of polyphenol compounds and polyphenol metabolites, and antioxidative and anti-inflammatory activity.

Detailed Description

Participants will be randomized based on age, sex and BMI, and will consume a low-polyphenol diet 2 days prior to the intervention. On the day of the study, baseline blood and urine samples will be collected after an overnight fast. Participants will consume the assigned beverage within 15 minutes and blood collected at 2, 4, 8, and 24 h (10 mL/blood draw; total blood volume per period = 50 mL). Urine will be collected for polyphenol analysis during the following periods: 0-3, 3-6, 6-9, 9-12, 12-24 hours. After a one-week washout period, participants will receive their second and then the third beverage in a cross-over design; blood and urine sampling will be repeated at each of the 3 intervention periods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Men & women; aged 18-35 years
  • BMI: 19-25 kg/m2
Exclusion Criteria
  • Any significant chronic disease, hypertension, ulcers, dyspepsia, lactose intolerance, allergy, psychotic illness
  • Had major gastrointestinal surgery or on prescription or surgical treatment
  • Any condition that may interfere with the digestion, absorption, metabolism or excretion of nutrients
  • Regularly smoked in the previous 6 months
  • On medication or ingested a prescribed drug at any time within the 14 days preceding study enrolment (excluding hormonal contraceptives and hormone replacement therapy) or over-the-counter preparation within 7 days preceding enrolment
  • Risk factors for AIDS or known HIV positive status
  • Pregnant or lactating
  • High intake of chocolate or similar high polyphenol foods
  • Regular intake of vitamin and polyphenol supplements
  • Drug and alcohol misuse
  • Currently participating or had participated in another clinical study during the previous 3 weeks
  • Donated blood in the previous 3 weeks
  • Exercise more than 3 times/week for longer than 45 min each time

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low Calorie Cranberry Juice CocktailLow Calorie Cranberry Juice CocktailBeverage containing cranberry: one dose of 15.2 ounces consumed within 15 minutes
Cranberry Extract BeverageCranberry Extract BeverageBeverage containing cranberry: one dose of 15.2 ounces consumed within 15 minutes
Non-Cranberry BeverageNon-Cranberry BeverageBeverage absent cranberry: one dose of 15.2 ounces consumed within 15 minutes
Primary Outcome Measures
NameTimeMethod
C-Reactive Protein (CRP) Concentrations in Plamsa0, 2, 4, 8, 24 h
Interleukin-1alpha (IL-1a) Concentrations in Plasma0, 2, 4, 8, 24 h
Interferon-gamma (IFN-y) Concentrations in Plasma0, 2, 4, 8, 24 h
Urinary Anti-bacteria Adhesion Activity0, 3, 6, 9, 12, 24 h
Interleukin-1beta (IL-1b) Concentrations in Plasma0, 2, 4, 8, 24 h
Tumor Necrosis Factor-alpha (TNF-a) Concentrations in Plasma0, 2, 4, 8, 24 h
Reduced Glutathione (GSH) Concentrations in Red Blood Cells0, 2, 4, 8, 24 h
Superoxide Dismutase (SOD) Activity in Red Blood Cells0, 2, 4, 8, 24 h
Glutathione Peroxidase (GPx) Activity in Red Blood Cells0, 2, 4, 8, 24 h
Oxidative Damage to DNA Assessed by Plasma 8-hydroxy-2'-Deoxyguanosine (8-OHdG)0, 2, 4, 8, 24 h
Nitric Oxide (NO) Concentrations in Plamsa0, 2, 4, 8, 24 h
Interleukin-2 (IL-2) Concentrations in Plasma0, 2, 4, 8, 24 h
Interleukin-4 (IL-4) Concentrations in Plasma0, 2, 4, 8, 24 h
Interleukin-6 (IL-6) Concentrations in Plasma0, 2, 4, 8, 24 h
Interleukin-8 (IL-8) Concentrations in Plasma0, 2, 4, 8, 24 h
Interleukin-10 (IL-10) Concentrations in Plasma0, 2, 4, 8, 24 h
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

WSU Bioactives Research Lab

🇺🇸

Pullman, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath